PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sachsenhausen Practice of General Medicine, HIV-Focus, Frankfurt am Main, Germany. Hentig@em.uni-frankfurt.de.\', \'HIVCENTER, Internal Medicine II, Goethe University Hospital, Frankfurt am Main, Germany. Hentig@em.uni-frankfurt.de.\', \'Institute of Clinical Pharmacology, Goethe University, Frankfurt am Main, Germany. Hentig@em.uni-frankfurt.de.\', \'Section Pharmacology, German AIDS Society, Frankfurt am Main, Germany. Hentig@em.uni-frankfurt.de.\', \'Praxis für Allgemeinmedizin / HIV-Schwerpunkt, Ziegelhüttenweg 1-3, 60598, Frankfurt am Main, Germany. Hentig@em.uni-frankfurt.de.\', \'HIVCENTER, Johann Wolfgang Goethe Universität, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. Hentig@em.uni-frankfurt.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00228-021-03108-x
?:doi
?:hasPublicationType
?:journal
  • European journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33660020
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.159
?:rankingScore_hIndex
  • 96
is ?:relation_isRelatedTo_publication of
?:title
  • Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all